VEDS Upcoming Clinical Trial Q&A with Aytu BioPharma and Hal Dietz, MD (AR101- Enzastuarin)

Nate Massari and Topher Brooke, with Aytu BioPharma, along with Hal Dietz, MD, will provide a brief background on the research leading up to the upcoming clinical trial for AR101 (Enzastaurin) for VEDS, and answer questions about steps in planning the trial and possible timeline.

Add to Calendar


Related Resource:

English Research Spanish VEDS Webinar

Speakers